Aelix Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $13M
Latest Deal Amount
  • Investors
  • 3

Aelix Therapeutics General Information

Description

Developer of a therapeutic vaccine designed to cure HIV (human immunodeficiency virus) infection. The company's vaccine is based on an observation of a T-cell immunogen that is able to elicit a strong broad and focused response against HIV and has the potential to radically transform the treatment of HIV infection, enabling patients to get cured of rare diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Therapeutic Devices
Primary Office
  • Parc Científic de Barcelona
  • Carrer Baldiri Reixac 4-8
  • 08028 Barcelona
  • Spain
+34 934 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aelix Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 11-Jan-2016 $13M 0000 000.00 Completed Generating Revenue
To view Aelix Therapeutics’s complete valuation and funding history, request access »

Aelix Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a therapeutic vaccine designed to cure HIV (human immunodeficiency virus) infection. The company's vaccine
Drug Discovery
Barcelona, Spain
12 As of 2021
0000
00.00 0000-00-00
00000000000 0000

0000000

. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo c
0000 000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000

00000000

uptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proi
0000 000000000
Rockville, MD
0 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aelix Therapeutics Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sarepta Therapeutics Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
000000000 00000000 Venture Capital-Backed Rockville, MD 0 000.00 0000000000 0 000.00
0000000 0000000000 Venture Capital-Backed Niel, Belgium 00 000.00 00000000000 000.00
0000000 Venture Capital-Backed Houston, TX 00 000.00 000000000 - 000.00
00 0000000 Venture Capital-Backed Copenhagen, Denmark 00 00000 00000000 00000
You’re viewing 5 of 31 competitors. Get the full list »

Aelix Therapeutics Patents

Aelix Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210145961-A1 Dosage regimens for vaccines Pending 14-Nov-2019 000000000

Aelix Therapeutics Executive Team (10)

Name Title Board Seat Contact Info
Christian Brander Ph.D Co-Founder & Chief Scientific Officer
Silvia López Director of Finance and Operations
Bonaventura Clotet Ph.D Co-Founder, Observer & Member of Scientific Advisory Board
Jordi Naval Co-Founder & Board Member
Thomas Hecht Ph.D Executive Chairman
You’re viewing 5 of 10 executive team members. Get the full list »

Aelix Therapeutics Board Members (8)

Name Representing Role Since
Bonaventura Clotet Ph.D Aelix Therapeutics Co-Founder, Observer & Member of Scientific Advisory Board 000 0000
Jeanne Bolger MD Johnson & Johnson Innovation - JJDC Board Member 000 0000
Jordi Naval Self Co-Founder & Board Member 000 0000
Karen Wagner Ysios Capital Board Member 000 0000
Pablo Cironi Ph.D Caixa Capital Risc Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Aelix Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aelix Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Caixa Capital Risc Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
Ysios Capital Venture Capital Minority 000 0000 000000 0
To view Aelix Therapeutics’s complete investors history, request access »